Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
While women have a lower risk for NAFLD, once present, the disease advanced more rapidly.
Relying solely on a liver biopsy to diagnose cirrhosis among people with hepatitis C likely misses three in four cases of the advanced stage o...
The good news: Not everyone living with chronic hep C needs to be treated for the virus. Even more encouraging: When treatment is necessary, t...
The use of noninvasive alternatives to liver biopsies to assess liver disease in people with HCV is becoming increasingly more common.
A noninvasive method for determining liver damage, called transient elastography, is nearly as accurate as a liver biopsy in people with hep...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.